Corticobasal degeneration

Seminars in Neurology

Volumn 21, Issue 1, 2001, Pages 49-58

  Stover, N P ^a   Watts, R L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atypical parkinsonism; Corticobasal degeneration; Neurodegenerative disease

Indexed keywords

ALPRAZOLAM; BACLOFEN; BROMOCRIPTINE; CARBIDOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLOZAPINE; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; PERGOLIDE; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE;

ADULT; AKINESIA; APRAXIA; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DYSTONIA; ELECTROPHYSIOLOGY; FEMALE; GLIOSIS; HUMAN; MALE; NEUROPATHOLOGY; PARKINSONISM; PRIORITY JOURNAL; REVIEW; RIGIDITY; STRIATONIGRAL DEGENERATION; SYMPTOM;

EID: 0035040338     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-13119     Document Type: Review

References (56)

1. Corticodentatonigral degeneration with neuronal achromasia: A progressive disorder of late adult life
2. Corticodentatonigral degeneration with neuronal achromasia
3. Natural history and survival of 14 patients with corticobasal degeneration confirmed ar postmortem examination
4. Corticobasal degeneration: A clinical study of 36 cases
5. Corticobasal ganglionic degeneration
6. Corticobasal degeneration: Neuropathological and clinical heterogeneity
7. Corticobasal degeneration
8. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy
9. Corticobasal degeneration. Clinical diagnostic criteria
10. Dementia as the most common presentation of cortical-basal ganglionic degeneration
11. Corticobasal degeneration. Myoclonus in corticobasal degeneration and other neurodegenerations
12. Corticobasal degeneration. Dystonia in corticobasal degeneration
13. Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study
14. Cortical basal ganglionic degeneration
15. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy
16. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
17. Corticobasal degeneration: Eye movement disorders in corticobasal degeneration
18. The nature of apraxia in corticobasal degeneration
19. Slowly progressive limb-kinetic apraxia
20. The neuropsychological pattern of corticobasal degeneration: Comparison with progressive supranuclear palsy and Alzheimer's disease
21. Dementia with pathological findings of corticobasal ganglionic degeneration
22. Corticobasal degeneration: Neuropsychiatric aspects of corticobasal degeneration
23. Corticobasal ganglionic degeneration
24. Corticobasal degeneration: Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias
25. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration
26. Differentiation of atypical parkinsonian syndromes with routine MRI
27. Corticobasal degeneration: Functional imaging studies in corticobasal degeneration
28. Cerebral blood flow correlates of higher brain dysfunctions in corticobasal degeneration
29. Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration
30. Corticobasal degeneration: A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography
31. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration
32. Electrophysiological comparison between corticobasal degeneration and progressive supranuclear palsy
33. Asymmetric changes in somatosensory evoked potentials correlate with limb apraxia in corticobasal degeneration
34. P300 findings in patients with corticobasal degeneration
35. Corticobasal ganglionic degeneration (CBD) with neuronal achromasia: Clinical pathological study of two cases
36. Immunocytochemical study of ballooned neurons in cortical degeneration with neuronal achromasia
37. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
38. Progressive supranuclear palsy: Neuropathologic and clinical heterogeneity
39. Normal and pathological tau proteins as factors for microtubule assembly
40. Neurodegenerative disorders with extensive tau pathology: A comparative study and review
41. Progressive supranuclear palsy
42. Recent advances in atypical parkinsonian disorders
43. Striatonigral degeneration
44. Striatonigral degeneration: A form of multiple system atrophy with clinical parkinsonism
45. Multiple system atrophy with autonomic failure
46. Clinical features and natural history of multiple system atrophy: An analysis of 100 cases
47. Morphological overlap between corticobasal degeneration and Pick's disease: A clinicopathological report
48. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration
49. Familial aphasia due to Pick's disease
50. Case 1: Rapidly progressive aphasia, apraxia, dementia, myoclonus and parkinsonism
51. Alien hand sign in association with Alzheimer's histopathology
52. Parkinsonismdementia complex, an endemic disease on the Island of Guam: I. Clinical features
53. Parkinsonismdementia complex on the Island of Guam: II. Pathological features
54. Creutzfeldt-Jakob disease presenting and evolving as rapidly progressive corticobasal degeneration
55. Clinical presentation and pharmacological therapy in corticobasal degeneration
56. The effects of unilateral ventral posterior medial pallidotomy in patients with Parkinson's disease and Parkinson's plus syndromes